SI1506222T1 - Himerni L1-proteini humanega papilomavirusa 16, ki obsegajo L2-peptid, delci, podobni virusu, pripravljeni iz njih, in postopek za pripravo delcev - Google Patents
Himerni L1-proteini humanega papilomavirusa 16, ki obsegajo L2-peptid, delci, podobni virusu, pripravljeni iz njih, in postopek za pripravo delcevInfo
- Publication number
- SI1506222T1 SI1506222T1 SI200331600T SI200331600T SI1506222T1 SI 1506222 T1 SI1506222 T1 SI 1506222T1 SI 200331600 T SI200331600 T SI 200331600T SI 200331600 T SI200331600 T SI 200331600T SI 1506222 T1 SI1506222 T1 SI 1506222T1
- Authority
- SI
- Slovenia
- Prior art keywords
- particles
- peptide
- dna sequence
- polypeptide
- human papillomavirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200203957 | 2002-05-17 | ||
PCT/IB2003/001912 WO2003097673A2 (en) | 2002-05-17 | 2003-05-19 | Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles. |
EP03727750A EP1506222B2 (en) | 2002-05-17 | 2003-05-19 | Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide, virus-like particles prepared therefrom and a method for preparing the particles |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1506222T1 true SI1506222T1 (sl) | 2009-10-31 |
Family
ID=29550639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200331600T SI1506222T1 (sl) | 2002-05-17 | 2003-05-19 | Himerni L1-proteini humanega papilomavirusa 16, ki obsegajo L2-peptid, delci, podobni virusu, pripravljeni iz njih, in postopek za pripravo delcev |
Country Status (13)
Country | Link |
---|---|
US (2) | US7407807B2 (sl) |
EP (1) | EP1506222B2 (sl) |
JP (2) | JP4614765B2 (sl) |
AT (1) | ATE424409T1 (sl) |
AU (1) | AU2003232951B2 (sl) |
CA (1) | CA2486450C (sl) |
CY (1) | CY1109257T1 (sl) |
DE (1) | DE60326449D1 (sl) |
DK (1) | DK1506222T3 (sl) |
ES (1) | ES2323634T5 (sl) |
PT (1) | PT1506222E (sl) |
SI (1) | SI1506222T1 (sl) |
WO (1) | WO2003097673A2 (sl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0228715D0 (en) * | 2002-12-09 | 2003-01-15 | Glaxosmithkline Biolog Sa | Vaccine |
CN103031310B (zh) | 2005-04-29 | 2018-09-14 | 开普敦大学 | 在植物中表达蛋白质 |
ES2310062B1 (es) | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
CN1328287C (zh) * | 2005-12-29 | 2007-07-25 | 西安交通大学 | Hpv16 l1蛋白模拟肽及其用于制备hpv16诊断试剂和疫苗的用途 |
CA2703066A1 (en) * | 2007-10-22 | 2009-04-30 | University Of Rochester | Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
CN102497880A (zh) * | 2009-06-25 | 2012-06-13 | 葛兰素史密丝克莱恩生物有限公司 | 新的人***状瘤病毒(hpv)蛋白构建体及其在预防hpv疾病中的用途 |
US20120225090A1 (en) * | 2009-08-03 | 2012-09-06 | The Johns Hopkins University | Methods for enhancing antigen-specific immune responses |
JP6153866B2 (ja) | 2010-05-25 | 2017-06-28 | キアゲン ガイサーズバーグ アイエヌシー. | 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ |
MX355352B (es) * | 2011-12-01 | 2018-04-17 | Univ Cape Town | Particulas quimericas de vph. |
US20160175426A1 (en) * | 2013-07-16 | 2016-06-23 | University Of Louisville Research Foundation, Inc. | Compositions for mucusal delivery, useful for treating papillomavirus infections |
JP7017811B2 (ja) * | 2020-02-13 | 2022-02-09 | 国立研究開発法人農業・食品産業技術総合研究機構 | ウイルス様粒子及びその使用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618536A (en) * | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
CA2202090C (en) * | 1994-10-07 | 2012-04-17 | Lutz Gissmann | Papilloma virus-like particles, fusion proteins as well as processes for their production |
GB9621091D0 (en) * | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
US6228368B1 (en) † | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
US6926897B1 (en) † | 1998-03-24 | 2005-08-09 | Medigene Aktiengesellschaft | Medicament for the avoidance or treatment of papillomavirus-specific tumour |
DE19812941A1 (de) † | 1998-03-24 | 1999-10-07 | Medigene Ag | Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor |
AU753391B2 (en) * | 1998-08-14 | 2002-10-17 | Merck Sharp & Dohme Corp. | Protein delivery system using human papillomavirus virus-like particles |
GB9921146D0 (en) † | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
DK2416798T3 (en) † | 2009-04-10 | 2018-01-08 | Univ Johns Hopkins | PAPILLOMAVIRUS-LIKE PARTICLES (VLP) AS WIDE-SPECIFIED VACCINES AGAINST HUMAN PAPILLOMAVIRUS (HPV) |
-
2003
- 2003-05-19 JP JP2004506346A patent/JP4614765B2/ja not_active Expired - Fee Related
- 2003-05-19 AT AT03727750T patent/ATE424409T1/de active
- 2003-05-19 DE DE60326449T patent/DE60326449D1/de not_active Expired - Lifetime
- 2003-05-19 DK DK03727750T patent/DK1506222T3/da active
- 2003-05-19 SI SI200331600T patent/SI1506222T1/sl unknown
- 2003-05-19 PT PT03727750T patent/PT1506222E/pt unknown
- 2003-05-19 ES ES03727750T patent/ES2323634T5/es not_active Expired - Lifetime
- 2003-05-19 US US10/514,878 patent/US7407807B2/en not_active Expired - Fee Related
- 2003-05-19 WO PCT/IB2003/001912 patent/WO2003097673A2/en active Application Filing
- 2003-05-19 AU AU2003232951A patent/AU2003232951B2/en not_active Ceased
- 2003-05-19 CA CA2486450A patent/CA2486450C/en not_active Expired - Fee Related
- 2003-05-19 EP EP03727750A patent/EP1506222B2/en not_active Expired - Lifetime
-
2008
- 2008-07-16 US US12/174,104 patent/US8163557B2/en not_active Expired - Lifetime
-
2009
- 2009-06-04 CY CY20091100595T patent/CY1109257T1/el unknown
-
2010
- 2010-06-16 JP JP2010137490A patent/JP2010263899A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP4614765B2 (ja) | 2011-01-19 |
ATE424409T1 (de) | 2009-03-15 |
AU2003232951A1 (en) | 2003-12-02 |
WO2003097673B1 (en) | 2004-04-22 |
EP1506222A2 (en) | 2005-02-16 |
JP2010263899A (ja) | 2010-11-25 |
PT1506222E (pt) | 2009-06-12 |
US20060035319A1 (en) | 2006-02-16 |
CA2486450A1 (en) | 2003-11-27 |
US20090047302A1 (en) | 2009-02-19 |
CY1109257T1 (el) | 2014-07-02 |
US7407807B2 (en) | 2008-08-05 |
WO2003097673A3 (en) | 2004-03-18 |
WO2003097673A2 (en) | 2003-11-27 |
DE60326449D1 (de) | 2009-04-16 |
US8163557B2 (en) | 2012-04-24 |
CA2486450C (en) | 2013-11-19 |
ES2323634T3 (es) | 2009-07-22 |
EP1506222B1 (en) | 2009-03-04 |
EP1506222B2 (en) | 2012-05-23 |
DK1506222T3 (da) | 2009-07-06 |
JP2006507797A (ja) | 2006-03-09 |
AU2003232951B2 (en) | 2009-07-23 |
ES2323634T5 (es) | 2012-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109257T1 (el) | Χιμαιρικες πρωτεϊνες l1 του ιου 16 ανθρωπινων θηλωματων που περιλαμβανουν l2 πεπτιδιο, ομοιαζοντα με ιο σωματιδια που παρασκευαζονται απο αυτες και μεθοδος παρασκευης των σωματιδιων | |
HK1082196A1 (en) | Production of human papillomavirus hbv-11 capsid protein l1 and virus-like particles | |
MXPA05005051A (es) | Vacuna de vector adenoviral. | |
MXPA03009354A (es) | Un clon infeccioso de adnc del virus del sindrome reproductivo y respiratorio porcino (prrs) norteamericano y sus usos. | |
IL175021A0 (en) | Chromatin insulator, its preparation and use in protein expression | |
JP2015037430A (ja) | パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法 | |
MY140664A (en) | Optimized expression of hpv 45 l1 in yeast | |
CA2342289A1 (en) | Treatment of cervical cancer | |
WO2002081709A3 (en) | Modified hpv e6 and e7 genes and proteins useful for vaccination | |
WO1999050424A3 (en) | Fusion protein comprising a sequence from a major coat protein of a papovavirus | |
DE60141014D1 (de) | Verfharen zur herstellung von herpes-simplex-virus-amplikons, die resultierenden amplikons und ihre verwendung | |
WO2004053091A3 (en) | STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES | |
AU1928201A (en) | Hbv/hcv virus-like particle | |
MXPA02012593A (es) | Particulas de tipo virus del virus de la diarrea viral bovina. | |
MXPA03000427A (es) | Preparacion de una proteina recombinante en una celula huesped procariotica. | |
WO2002044323A3 (en) | Vectors for expressing heterologous peptides at the amino-terminus of potyvirus coat protein, methods for use thereof, plants infected with same and methods of vaccination using same | |
WO2003078566A3 (en) | Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof | |
WO2002002142B1 (en) | Papillomavirus vaccine | |
EP1897944A3 (en) | IL-17 homologous polypeptides and therapeutic uses thereof |